Knocking down disease with siRNAs. [Cell. 2006] - PubMed

Review Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs. [Annu Rev Biomed Eng. 2006]
Review Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
Dykxhoorn DM, Lieberman J. Annu Rev Biomed Eng. 2006; 8:377-402.
Review Targeted delivery systems of small interfering RNA by systemic administration. [Drug Metab Pharmacokinet. 2007]
Review Targeted delivery systems of small interfering RNA by systemic administration.
Kawakami S, Hashida M. Drug Metab Pharmacokinet. 2007 Jun; 22(3):142-51.
Review Interfering with disease: opportunities and roadblocks to harnessing RNA interference. [Trends Mol Med. 2003]
Review Interfering with disease: opportunities and roadblocks to harnessing RNA interference.
Lieberman J, Song E, Lee SK, Shankar P. Trends Mol Med. 2003 Sep; 9(9):397-403.
Review Targeted gene silencing by small interfering RNA-based knock-down technology. [Curr Pharm Biotechnol. 2004]
Review Targeted gene silencing by small interfering RNA-based knock-down technology.
Zhang J, Hua ZC. Curr Pharm Biotechnol. 2004 Feb; 5(1):1-7.
Review The silent treatment: siRNAs as small molecule drugs. [Gene Ther. 2006]
Review The silent treatment: siRNAs as small molecule drugs.
Dykxhoorn DM, Palliser D, Lieberman J. Gene Ther. 2006 Mar; 13(6):541-52.

Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy. [PLoS One. 2011]
Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy.
Liao H, Irvine AD, Macewen CJ, Weed KH, Porter L, Corden LD, Gibson AB, Moore JE, Smith FJ, McLean WH, et al. PLoS One. 2011; 6(12):e28582. Epub 2011 Dec 12.
Persistence of different forms of transient RNAi during apoptosis in mammalian cells. [PLoS One. 2010]
Persistence of different forms of transient RNAi during apoptosis in mammalian cells.
Kandan-Kulangara F, Shah RG, Affar el B, Shah GM. PLoS One. 2010 Aug 18; 5(8):e12263. Epub 2010 Aug 18.
Noninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver. [Mol Ther. 2010]
Noninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver.
Tao W, Davide JP, Cai M, Zhang GJ, South VJ, Matter A, Ng B, Zhang Y, Sepp-Lorenzino L. Mol Ther. 2010 Sep; 18(9):1657-66. Epub 2010 Jul 13.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Knocking down disease with siRNAs.
Knocking down disease with siRNAs.
Cell. 2006 Jul 28 ;126(2):231-5.

PubMed
Running interference: prospects and obstacles to using small interfering RNAs as...
Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
Annu Rev Biomed Eng. 2006 ;8:377-402.

PubMed
siRNA-directed inhibition of HIV-1 infection.
siRNA-directed inhibition of HIV-1 infection.
Nat Med. 2002 Jul ;8(7):681-6. Epub 2002 Jun 3 .

PubMed
Silencing viral infection.
Silencing viral infection.
PLoS Med. 2006 Jul ;3(7):e242. Epub 2006 Jul 25 .

PubMed
Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-indepen...
Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death.
Cell. 2008 May 16 ;133(4):681-92.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed